Skip to content
Search

Latest Stories

New Oxford modelling confirms ethnicity and poverty as Covid risk factors

New Oxford modelling confirms ethnicity and poverty as Covid risk factors

A new modelling has recognised ethnicity and deprivation as risk factors for severe Covid for the first time.

The risk analysis tool from a team at Oxford University, commissioned by the chief medical officer for England, Chris Whitty, has taken into account a multiplicity of health conditions and circumstances that increase people’s likelihood of death, from obesity and severe mental health problems to homelessness, reported The Guardian.


Following the analysis, campaigners have urged for higher priority for vaccination for black, Asian and minority ethnic groups.

The new tool-QCovid-has been in development for some months by a team led by Julia Hippisley-Cox, a professor of clinical epidemiology and clinical practice at Oxford. The methodology underpinning it was published in October.

The tool suggested that the shielding list should nearly double, adding 1.7 million people to the current 2.2 million who already isolate themselves at home. It was based on data from the health records of more than 8 million people during the first wave of the pandemic.

“Since March we have been pleading with Matt Hancock for race and deprivation to be considered as risk factors, and safeguarding measures to be implemented as a result. The new measures are by no means a complete solution. In fact, they’re something of a halfway house. But they are a tremendously important step in the right direction and should be welcomed with open arms," Dr Halima Begum, chief executive, Runnymede Trust, told The Guardian

“By pulling together a trifecta of risk factors – ethnicity, social deprivation and body mass index – we offer a greatly expanded group of vulnerable people far higher levels of protection.”

"We had long highlighted the fact that people from an ethnic minority background, especially with underlying conditions, are at high risk of death from Covid-19 and that those from poorer areas are also twice as likely to die from this terrible disease," said Dr Chaand Nagpaul, chair of the British Medical Association council.

“Many of these patients fall outside of the current JCVI (Joint Committee on Vaccines and Immunisation) priority groups for the Covid vaccine, and so it is now vitally important that these patients are prioritised for vaccination and urgently protected against the deadly effects of Covid-19.”

Among the many factors the model takes into account are ethnicity, postcode and body mass index. There have been higher rates of death among people from black, ethnic minority and Asian communities and also people from poorer neighbourhoods with cramped housing.

According to the report, all those newly identified will get a letter from their GP suggesting they shield until at least 31 March, which is later than the current date of 21 February.

Those affected are advised to stay at home full time and offered services such as delivery of their medicines. Statutory sick pay is available and those who shop for them can get priority at supermarkets.

Dr Jenny Harries, the deputy chief medical officer for England, said the new tool enabled health workers to go further in protecting the most vulnerable in the community.

“This new model is a tribute to our health and technology researchers. The model will help the NHS identify further individuals who may be at high risk from Covid-19 due to a combination of personal and health factors. Those most vulnerable to Covid-19 can benefit from both the protection that vaccines provide, and from enhanced advice, including shielding and support, if they choose it," she told The Guardian.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Dickie and Watt

Dickie and Watt launched BrewDog at the age of 24

Getty Images

BrewDog co-founder Martin Dickie leaves after 17 years as James Watt steps back

Highlights:

  • Martin Dickie has announced his departure from BrewDog and the alcohol industry.
  • He co-founded the Ellon-based brewer with James Watt in 2007.
  • Dickie cited family time and personal reasons for his exit.
  • His departure follows recent bar closures as part of a company restructuring.
  • BrewDog confirmed no further leadership changes will follow.

BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.

Early beginnings

Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.

Keep ReadingShow less